Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8168179 Treatment method using anti-PD-L1 antibody

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 10, 2009
Date of Patent
May 1, 2012
Patent Application Number
12538698
Patent Citations Received
‌
US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
0
‌
US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11708412 Methods for treating hematologic cancers
0
‌
US Patent 11712433 Compositions comprising PKM2 modulators and methods of treatment using the same
0
‌
US Patent 11746103 ALK-5 inhibitors and uses thereof
‌
US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies
‌
US Patent 11767361 Method of treating lung cancer
‌
US Patent 11773175 Antibodies, uses and methods
‌
US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8168179
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 8168179 Treatment method using anti-PD-L1 antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.